There is so much misinformation out there about hormones and women’s health, especially estrogen.
So I’m excited to share my in-depth conversation with Dr. Felice Gersh about women’s hormones and the different phases of perimenopause and menopause.
We discuss the flawed study that generated so much fear and misinformation about estrogen and cancer, the difference between synthetic and bioidentical hormones, the role diet and your gut microbiome play in balancing hormones, and so much more.
Dr. Felice Gersh is board certified in OB-GYN and Integrative Medicine. She taught as an assistant clinical professor at the Keck USC School of Medicine for 12 years and is the founder and director of the Integrative Medical Group of Irvine, California.
A globally recognized expert on women’s health, Dr. Gersh regularly speaks at conferences around the world and is also the best-selling author of PCOS SOS and her most recent book, Menopause: 50 Things You Need to Know about what to expect during the three phases of menopause.
Listen to the full episode to hear:
- Why the hormone combination used in the Women’s Health Initiative study caused so many problems
- How estrogen can actually protect you from reproductive cancers and why this changes with age
- How chronic pro-inflammatory states and hormonal imbalances contribute to the negative effects of aging
- Why we are seeing more cancers in young, premenopausal women
- How endocrine disruptors in food and the environment contribute to rising rates of autoimmune disorders, cancers, and menstrual disorders like PCOS
Learn more about Dr. Felice Gersh:
- Women’s Health Initiative is Fundamentally Flawed. Gender Medicine, Volume 2, Issue 1, 2005.
- A Critique of the Women’s Health Initiative Hormone Therapy Study. Fertility and Sterility, Volume 84, Issue 6, 2005.
- In Defense of Estrogen, Journal of Orthomolecular Medicine. Vol. 22, No. 3, 2007.
- Environmental Causes of Cancer: Endocrine Disruptors as Carcinogens. Nature Reviews Endocrinology, 363–370 (2010).
- Polycystic Ovary Syndrome (PCOS) and Endocrine Disrupting Chemicals (EDCs). Reviews in Endocrine and Metabolic Disorders. 16, 365–371 (2015).
- Menopause and hormone replacement therapy in the 21st century. Heart 2020;106:479-481.
- Postmenopausal hormone therapy for cardiovascular health: the evolving data. Heart Epub ahead of print: 2020. doi:10.1136